SCHEMBL30810293

SCHEMBL30810293

CCc1cc(Cl)cc(C(=O)O)c1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.76
HPGD P15428 2/20 0.76
HSD17B10 Q99714 2/20 0.76
AKR1C2 P52895 4/20 0.60
AKR1C1 Q04828 4/20 0.60
AKR1C4 P17516 1/20 0.60
AKR1C3 P42330 1/20 0.60
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CYP3A4 P08684 1/20 0.44
TP53 P04637 1/20 0.42
PTPN1 P18031 4/20 0.42
PTPN2 P17706 2/20 0.42
PTPN6 P29350 2/20 0.42
HMGB1 P09429 2/20 0.42
CXCL12 P48061 2/20 0.42
KDM4E B2RXH2 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14564097 1.00 ALDH1A1 (0.76) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL9250293 0.82 HSD17B10 (0.61) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL45872 0.81 GABRA1 (0.50) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL30810266 0.80 HPGD (0.50) ALDH1A1HPGDHSD17B10CA1CA2
SCHEMBL39260 0.80 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL15375739 0.79 HMGB1 (0.48) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL10710661 0.79 AKR1C2 (0.58) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL28727228 0.79 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL21986386 0.79 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1
SCHEMBL5640021 0.79 ALDH1A1 (0.53) ALDH1A1HPGDHSD17B10AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed